Florian Baudin
Overview
Explore the profile of Florian Baudin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathis T, Baudin F, Mariet A, Augustin S, Bricout M, Przegralek L, et al.
J Clin Invest
. 2024 Jul;
134(17).
PMID: 39012703
Neovascular age-related macular degeneration (nAMD) remains a major cause of visual impairment and puts considerable burden on patients and health care systems. l-DOPA-treated Parkinson's disease (PD) patients have been shown...
2.
Creuzot Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, et al.
Acta Ophthalmol
. 2023 Oct;
102(4):e548-e556.
PMID: 37874253
Objective: To describe the management of diabetic macular oedema (DME) patients from the entire French population between 2012 and 2018. Methods: In this retrospective longitudinal study, we identified adults treated...
3.
Creuzot Garcher C, Srour M, Baudin F, Dot C, Nghiem-Buffet S, Girmens J, et al.
Ophthalmol Ther
. 2023 Aug;
12(5):2687-2701.
PMID: 37531029
Introduction: The aim of this study was to describe the management of neovascular age-related macular degeneration (nAMD) in French patients between 2008 and 2018. Methods: This was a retrospective longitudinal...
4.
Creuzot-Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, et al.
Pharmaceutics
. 2022 Nov;
14(11).
PMID: 36365148
Aim: LANDSCAPE aimed to estimate the annual incidence and prevalence of treated diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) between 2008 and 2018. Methods: This French nationwide observational...
5.
Baudin F, Benzenine E, Mariet A, Ben Ghezala I, Bron A, Daien V, et al.
Pharmaceutics
. 2022 Oct;
14(10).
PMID: 36297568
The dramatic increase in intravitreal injections (IVTs) has been accompanied by a greater need for safer procedures. The ongoing debate about topical antibiotic prophylaxis after IVTs emphasizes the importance of...
6.
Creuzot-Garcher C, Srour M, Baudin F, Daien V, Dot C, Nghiem-Buffet S, et al.
Ophthalmol Sci
. 2022 Oct;
2(1):100114.
PMID: 36246186
Purpose: This study aimed to estimate the incidence and prevalence of neovascular age-related macular degeneration (nAMD) in the French population between 2008 and 2018. Design: This was a retrospective, longitudinal...
7.
Ben Ghezala I, Mariet A, Benzenine E, Bardou M, Bron A, Gabrielle P, et al.
J Pers Med
. 2022 Sep;
12(9).
PMID: 36143159
This nationwide population-based cohort study aimed to describe the use of intravitreal injections (IVTs) of anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids in pregnant women in France and to...
8.
Merad M, Verite F, Baudin F, Ben Ghezala I, Meillon C, Bron A, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36013153
(1) Background: The aim was to describe the rate and outcomes of cystoid macular edema (CME) after pars plana vitrectomy (PPV) for primary rhegmatogenous retinal detachment (RRD) and to identify...
9.
Carre C, Baudin F, Buteau B, Martine L, Gregoire S, Vasku G, et al.
Acta Ophthalmol
. 2022 Aug;
101(1):e61-e68.
PMID: 35920328
Purpose: The aim of this study was to evaluate docosahexaenoic acid (DHA) as a potential antifibrotic agent after glaucoma filtration surgery (GFS) in rats. Methods: A total of 36 10-week-old...
10.
Ben Ghezala I, Mariet A, Benzenine E, Gabrielle P, Baudin F, Quantin C, et al.
Am J Ophthalmol
. 2022 Jul;
243:91-97.
PMID: 35907474
Purpose: To report the incidence of postoperative rhegmatogenous retinal detachment after macular surgery in France between 2006 and 2016, and identify associated factors. Design: Nationwide, population-based, cohort study. Methods: All...